慢病毒
LNP “上场”
超越T细胞
小结
-上下滑动查看参考资料-
[1]https://www.nature.com/articles/d41573-024-00150-z
[2]https://www.umoja-biopharma.com/news/abbvie-and-umoja-biopharma-announce-strategic-collaboration-to-develop-novel-in-situ-car-t-cell-therapies/
[3]https://interiusbio.com/2024/07/interius-biotherapeutics-receives-hrec-approval-and-ctn-clearance-from-the-tga-to-commence-a-phase-1-clinical-trial-for-its-first-in-class-in-vivo-car-therapeutic-for-b-cell-malignancies-will-initiate/
[4]https://interiusbio.com/wp-content/uploads/2023/06/Interius-Bio-Data-Poster-June-2023-1.pdf
[5]https://www.nature.com/articles/nbt1060
[6]https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220327/
[7]https://ashpublications.org/blood/article/144/9/977/516468/In-vivo-CAR-T-cell-generation-in-nonhuman-primates
[8]https://www.umoja-biopharma.com/news/umoja-biopharma-announces-fda-clearance-of-ind-application-for-ub-vv111-a-cd19-directed-in-situ-car-t-for-hematologic-malignancies/
[9]https://www.capstantx.com/posts/capstan-therapeutics-announces-175m-oversubscribed-series-b-financing/
[10]https://ir.carismatx.com/news-releases/news-release-details/carisma-and-moderna-expand-collaboration-develop-two-vivo-car-m
[11]https://mp.weixin.qq.com/s/Cm4hwz6DpItw7faCiXMgNw
[12]https://mp.weixin.qq.com/s/KiliqhjYhzssYUBytaLanQ
[13]https://mp.weixin.qq.com/s/3Hsscbzz45oiSqOiMDQG9A
